| 05th week of 2018 patent applcation highlights part 9 |
| Patent application number | Title | Published |
|---|
| 20180028525 | COMPOSITIONS AND METHODS FOR ACHIEVING SUSTAINED THERAPEUTIC DRUG CONCENTRATIONS IN A SUBJECT | 2018-02-01 |
| 20180028526 | NALMEFENE FOR REDUCTION OF ALCOHOL CONSUMPTION IN SPECIFIC TARGET POPULATIONS | 2018-02-01 |
| 20180028527 | ABUSE DETERRENT COMPOSITIONS AND METHODS OF MAKING SAME | 2018-02-01 |
| 20180028530 | Role of N-2-Hydroxy-Ethyl-Piperazine-N'-2-Ethane Sulfonic Acid (HEPES) in Pain Control and Reversal of Demyelinization Injury | 2018-02-01 |
| 20180028531 | USE OF PLINABULIN IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITORS | 2018-02-01 |
| 20180028532 | AMINOHETEROARYL BENZAMIDES AS KINASE INHIBITORS | 2018-02-01 |
| 20180028533 | Medicinal solution to be continuously or pulse-delivered to the eye for treating ophthalmological conditions/maladies | 2018-02-01 |
| 20180028534 | SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRI- MIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE | 2018-02-01 |
| 20180028535 | 3-HYDROXYPYRIMIDINE-2,4-DIONE-5-CARBOXAMIDES AS POTENT INHIBITORS OF HIV | 2018-02-01 |
| 20180028536 | INHIBITORY EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS | 2018-02-01 |
| 20180028537 | Novel Formulations of a Bruton's Tyrosine Kinase Inhibitor | 2018-02-01 |
| 20180028538 | NOVEL COMPOSITION FOR TREATMENT OF ESSENTIAL THROMBOCYTHEMIA | 2018-02-01 |
| 20180028539 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | 2018-02-01 |
| 20180028540 | ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF | 2018-02-01 |
| 20180028541 | CERTAIN (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS FOR TREATING BRONCHIECTASIS | 2018-02-01 |
| 20180028542 | PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME | 2018-02-01 |
| 20180028543 | HYPOLIPIDEMIC COMPOSITION AND USE THEREOF | 2018-02-01 |
| 20180028544 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2018-02-01 |
| 20180028545 | PHOSPHOLIPID COMPOSITIONS | 2018-02-01 |
| 20180028546 | COMPOUNDS AND COMPOSITIONS FOR IMPROVING POWER OUTPUT AND OXYGEN EFFICIENCY | 2018-02-01 |
| 20180028547 | COMPOUND FROM THE AVERMECTIN FAMILY FOR TREATING AND/OR PREVENTING FOLLICULITIS | 2018-02-01 |
| 20180028548 | PHARMACEUTICAL COMPOSITIONS | 2018-02-01 |
| 20180028549 | PHARMACEUTICAL COMPOSITIONS | 2018-02-01 |
| 20180028550 | USE OF ALBIFLORIN OR PHARMACEUTICALLY ACCEPTABLE SALT FOR PREVENTION AND/OR TREATMENT OF IRRITABLE BOWEL SYNDROME | 2018-02-01 |
| 20180028551 | Treatment of Diseases Using Combination of Ultraviolet Blood Irradiation and Antibiotics | 2018-02-01 |
| 20180028552 | COMBINATION THERAPY FOR TREATING CANCER | 2018-02-01 |
| 20180028553 | USE OF STING AGONIST AS CANCER TREATMENT | 2018-02-01 |
| 20180028554 | Oligomers Having Bicyclic Scaffold Moeities | 2018-02-01 |
| 20180028555 | 2'-METHOXY SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS | 2018-02-01 |
| 20180028556 | METHODS OF TREATING OPTIC DISORDERS | 2018-02-01 |
| 20180028557 | HYBRID OLIGONUCLEOTIDES AND USES THEREOF | 2018-02-01 |
| 20180028558 | THERAPEUTIC POLYSACCHARIDE MIDI-GAGR AND RELATED MATERIALS AND METHODS | 2018-02-01 |
| 20180028559 | SELENIUM-CONTAINING COMPOSITIONS AND USES THEREOF | 2018-02-01 |
| 20180028560 | SELENIUM-CONTAINING COMPOSITIONS AND USES THEREOF | 2018-02-01 |
| 20180028561 | METHOD FOR PREPARING A LIPOSOMAL REHYDRATION SALT FORMULATION | 2018-02-01 |
| 20180028562 | METHODS OF TREATING OR PREVENTING INFLAMMATION AND HYPERSENSITIVITY WITH OXIDATIVE REDUCTIVE POTENTIAL WATER SOLUTION | 2018-02-01 |
| 20180028563 | COMBINATION THERAPIES FOR BLADDER CANCER | 2018-02-01 |
| 20180028564 | METHODS FOR PREVENTING OR TREATING INFECTIOUS DISEASES CAUSED BY EXTRACELLULAR MICROORGANISMS, INCLUDING ANTIMICROBIAL-RESISTANT STRAINS THEREOF, USING GALLIUM COMPOUNDS | 2018-02-01 |
| 20180028565 | SILVER OXIDE FORMULATIONS | 2018-02-01 |
| 20180028566 | GAMMA DELTA T CELLS AS A TARGET FOR TREATMENT OF SOLID TUMORS | 2018-02-01 |
| 20180028567 | ENGINEERING AND DELIVERY OF THERAPEUTIC COMPOSITIONS OF FRESHLY ISOLATED CELLS | 2018-02-01 |
| 20180028568 | CELL-BASED COMPOSITION AND USE THEREOF FOR TREATMENT OF PSORIASIS AND AUTOIMMUNE DISEASES | 2018-02-01 |
| 20180028569 | COMPOSITION DERIVED FROM MAMMALIAN UMBILICAL CORD AND WHARTONS JELLY FOR USE IN THERAPEUTIC AND REGENERATIVE APPLICATIONS | 2018-02-01 |
| 20180028570 | Angiogenic Factors | 2018-02-01 |
| 20180028571 | METHOD FOR TREATING CANCER | 2018-02-01 |
| 20180028572 | METHODS FOR MAKING AND USING SINOATRIAL NODE-LIKE PACEMAKER CARDIOMYOCYTES AND VENTRICULAR-LIKE CARDIOMYOCYTES | 2018-02-01 |
| 20180028573 | Compositions and Methods for Transplantation of Colon Microbiota | 2018-02-01 |
| 20180028574 | Compositions and Methods for Transplantation of Colon Microbiota | 2018-02-01 |
| 20180028576 | COMPOSITIONS AND METHODS FOR CHARACTERIZING AND RESTORING GASTROINTESTINAL, SKIN, AND NASAL MICROBIOTA | 2018-02-01 |
| 20180028577 | BACTERIA OVER-EXPRESSING C-DI-AMP AND THERAPEUTIC METHODS | 2018-02-01 |
| 20180028578 | MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE | 2018-02-01 |
| 20180028579 | USE OF COLLINSELLA FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE | 2018-02-01 |
| 20180028580 | BIFIDOBACTERIUM BREVE CBT BR3 STRAIN FOR PROMOTION OF GROWTH AND NUTRACEUTICAL COMPOSITION FOR PROMOTION OF GROWTH CONTAINING THE SAME | 2018-02-01 |
| 20180028581 | BACTERIAL COMPOSITION AND ITS USE | 2018-02-01 |
| 20180028582 | PROBIOTIC AND POLYPHENOL AGAINST NEURODEGENERATION | 2018-02-01 |
| 20180028583 | CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB | 2018-02-01 |
| 20180028584 | COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING BURNOUT SYNDROME | 2018-02-01 |
| 20180028585 | Slim and aqua concentrate having standardized and triple salt stabilized (-)-Hydroxycitric acid from Garcinia cambogia extract for making concentrate and slimming water and their derived product for weight management | 2018-02-01 |
| 20180028586 | PROCEDURE FOR PREPARATION OF A PRODUCT BASED OF THE LEAVES OF THE PLANT SEDUM TELEPHIUM FOR THE TREATMENT OF NAILS INFECTED WITH ONYCHOMYCOSIS. | 2018-02-01 |
| 20180028587 | COMPOSITION COMPRISING AN ONION EXTRACT AND LIPOSOMES | 2018-02-01 |
| 20180028588 | FORMULATION, PREPARATION METHOD AND USE OF CHINESE HERBAL MEDICINE COMPOSITION FOR SOOTHING LIVER | 2018-02-01 |
| 20180028589 | Pain Relief Composition | 2018-02-01 |
| 20180028590 | Unknown | 2018-02-01 |
| 20180028591 | MALE AND FEMALE INFERTILITY HERBAL COMPOSITION | 2018-02-01 |
| 20180028592 | A POLYHERBAL COMPOSITION FOR IDIOPATHIC PULMONARY FIBROSIS (IPF) | 2018-02-01 |
| 20180028593 | TERMINAL NANOFILTRATION OF SOLUBILIZED PROTEIN COMPOSITIONS FOR REMOVAL OF IMMUNOGENIC AGGREGATES | 2018-02-01 |
| 20180028595 | COMPOSITIONS AND METHODS FOR REGULATING BLOOD PRESSURE | 2018-02-01 |
| 20180028596 | ANG-(1-7) Derivative Oligopeptides for the Treatment of Pain and Other Indications | 2018-02-01 |
| 20180028598 | Compostions for Treating Dry Eye Disease | 2018-02-01 |
| 20180028599 | MCJ AGONISTS AND USES THEREFOR | 2018-02-01 |
| 20180028600 | NOVEL RECOMBINANT EXOSOME AND USE THEREOF | 2018-02-01 |
| 20180028601 | METHODS AND COMPOSITIONS FOR TREATING CANCER | 2018-02-01 |
| 20180028602 | METHOD OF INHIBITING MICROGLIAL CELL MIGRATION AND TREATING TRAUMATIC BRAIN INJURY | 2018-02-01 |
| 20180028603 | A PROTEIN BASED ON ZG16 FOR USE AS A MEDICAMENT | 2018-02-01 |
| 20180028604 | SEMAPHORIN 3A FOR TREATMENT AND ASSESSMENT OF SEVERITY OF INFLAMMATORY BOWEL DISEASE | 2018-02-01 |
| 20180028605 | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER COMPRISING EI24 PROTEIN OR ITS ENCODING GENE | 2018-02-01 |
| 20180028606 | USE OF HLA-B27 HOMODIMERS FOR CANCER TREATMENT | 2018-02-01 |
| 20180028607 | METHODS OF TREATMENT FOR RETINAL DISEASES | 2018-02-01 |
| 20180028608 | COMPOSITIONS AND METHODS TO DIAGNOSE DIABETES AND/OR TO TREAT NEGATIVE EFFECTS OF DIABETES | 2018-02-01 |
| 20180028609 | TREATMENT | 2018-02-01 |
| 20180028610 | METHODS FOR DETECTING CARDIAC DAMAGE | 2018-02-01 |
| 20180028611 | COMPOSITIONS AND METHODS TO INDUCE TARGETED APOPTOSIS BY MODULATING PROTEIN TYROSINE PHOSPHATASE 13 (PTPN13) | 2018-02-01 |
| 20180028612 | Compositions and methods of using a soluble TNF-alpha receptor modified for increased half-life | 2018-02-01 |
| 20180028613 | AORTOPATHY | 2018-02-01 |
| 20180028614 | USE OF INTERLEUKIN-22 IN THE TREATMENT OF FATTY LIVER DISEASE | 2018-02-01 |
| 20180028615 | COMPOSITIONS AND METHODS USING IL-8 TO IMPROVE MILK PRODUCTION AND REPRODUCTIVE HEALTH IN MAMMALS | 2018-02-01 |
| 20180028616 | TARGETED HUMAN-INTERFERON FUSION PROTEINS | 2018-02-01 |
| 20180028617 | METHODS OF TREATING MILD BRAIN INJURY AND POST-TRAUMATIC STRESS DISORDER | 2018-02-01 |
| 20180028618 | COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA | 2018-02-01 |
| 20180028619 | LKKTET AND/OR LKKTNT PEPTIDE COMPOSITIONS WHICH ARE LYOPHILIZED OR IN A FORM CAPABLE OF BEING LYOPHILIZED | 2018-02-01 |
| 20180028620 | Composition for Controlled Ovarian Stimulation | 2018-02-01 |
| 20180028621 | METHODS OF INDUCING INDOLAMINE 2,3 - DIOXYGENASE (IDO) | 2018-02-01 |
| 20180028622 | TREATMENT OF OSTEOPOROSIS | 2018-02-01 |
| 20180028623 | USE OF PERTUSSIS TOXIN AS A THERAPEUTIC AGENT | 2018-02-01 |
| 20180028624 | Injection Paradigm For Administration Of Botulinum Toxins | 2018-02-01 |
| 20180028625 | ADMINISTRATION OF PLANT EXPRESSED ORAL TOLERANCE AGENTS | 2018-02-01 |
| 20180028626 | IMMUNOTHERAPEUTIC VACCINE AND ANTIBODY COMBINATION THERAPY | 2018-02-01 |
| 20180028627 | TREATMENT VACCINE FOR PROSTATE CANCER | 2018-02-01 |
| 20180028628 | USE OF TOLL-LIKE RECEPTOR AGONIST FOR TREATING CANCER | 2018-02-01 |
| 20180028629 | IMMUNOGENIC/THERAPEUTIC GLYCAN COMPOSITIONS AND USES THEREOF | 2018-02-01 |
